Current Alzheimer Research

Papers
(The median citation count of Current Alzheimer Research is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Construction of lncRNA-ceRNA Networks to Reveal the Potential Role of Lfng/Notch1 Signaling Pathway in Alzheimer’s Disease27
Recent Updates on Alzheimer’s Disease: Pathogenesis, Pathophysiology, Molecular Approaches and Natural Bioactive Compounds Used in Contemporary Time to Alleviate Disease25
Serine Racemase Expression Differentiates Aging from Alzheimer’s Brain23
Early Memory Impairment is Accompanied by Changes in GluA1/ p-GluA1 in APP/PS1 Mice21
Anthocyanidins Intake is Associated with Alzheimer’s Disease Risk in Americans over 60 Years of Age: Data from NHANES 2007-2008, 2009-2010, and 2017-201820
Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial20
Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases19
Role of GSK-3 Inhibition in Alzheimer’s Disease Therapy19
Associations between Physical Performance Tests with Cognitive Changes: The Moderating Effect of Cognitive Status18
Microglia PTK2B/Pyk2 in the Pathogenesis of Alzheimer’s Disease18
Advances in Nose-to-Brain Delivery Systems for Effective Alzheimer's Disease Management17
Comparative Efficacy and Safety of Cholinesterase Inhibitors and NMDA Receptor Antagonists in Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials16
Development and Psychometric Validation of the 27 Item Zarit Caregiver Interview for Alzheimer’s Disease (ZCI-AD-27)15
The Cause-and-Consequence Relationships between Domestic Abuse and Alzheimer’s Disease: Identification of Five Subtypes15
Current Progress on Central Cholinergic Receptors as Therapeutic Targets for Alzheimer's Disease14
Mitochondrial Dysfunction in Alzheimer’s Disease: Beyond Energy Failure Toward a Pathogenic Nexus14
Blood Neurofilament Light Chain in Different Types of Dementia14
Effects of the Recurrent and Different Doses of Ketamine Exposure on Anxiety-like Behaviors and Locomotor Activity in Juvenile Rats14
Trafficking of Muscarinic 1 Acetylcholine Receptor Regulated by VPS35 in Alzheimer's Disease13
Acknowledgements to Reviewers13
Glial-derived Neuroinflammation induced with Amyloid-beta-peptide Plus Fibrinogen Injection in Rat Hippocampus11
Multifunctional Tasks and an Energy Crisis are Crucial Players in Determining the Vulnerability of the Entorhinal Cortex to Early Damage in Alzheimer’s Disease11
Improving Quality of Life in Dementia through Tailored Interventions: A Systematic Review from Saudi Arabia11
The Association of Allergy-Related and Non-Allergy-Related Olfactory Impairment with Cognitive Function in Older Adults: Two Cross- Sectional Studies11
Associations between Handwriting Decline and Cognitive-Motor Impairment in Dementia11
Imagine Yourself Dancing Waltz: The Effect of Imagination on Memory in Alzheimer’s Disease11
Retraction Notice: Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer's Transgenic Mice10
Analysis of Alzheimer's Disease-Related Mortality Rates Among the Elderly Populations Across the United States: An Analysis of Demographic and Regional Disparities from 1999 to 202010
Acupuncture Improves Synaptic Plasticity of SAMP8 Mice through the RhoA/ROCK Pathway10
Influence of Inflammation, Gut Microbiota, and Stress on Cognition and Oral Health Therapies10
Artificial Intelligence in Eye Movements Analysis for Alzheimer’s Disease Early Diagnosis9
The Framework for an Integrative Theory of Alzheimer’s Disease9
Mapping the Connection Between Circadian Rhythms, Metabolism, and Neurodegeneration: Exploring Therapeutic Strategies9
Roles of Microglia in AD Pathology9
Radio-Anatomical Assessment of Cerebellum Volume in Individuals with Alzheimer's Disease8
Pharmacological Attributes of Fenugreek with Special Reference to Alzheimer’s Disease8
Associations Between Metabolomics Findings and Brain Hypometabolism in Mild Cognitive Impairment and Alzheimer’s Disease8
The Association between the rs6656401 Locus of the CR1 Gene and Structural Alterations of Brain Effects in Han Chinese Patients with Alzheimer's Disease8
The Importance of Long-term Partner Observation in Cognitive Evaluation: A Very Early Creutzfeldt-Jakob Disease in a Patient with Mild Cognitive Impairment8
Landmark Model-based Individual Dynamic Prediction of Conversion from Mild Cognitive Impairment to Alzheimer’s Disease using Cognitive Screening8
Amisulpride Decreases Tau Protein Hyperphosphorylation in the Brain of OXYS Rats7
Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue7
Common Neuropsychiatric Symptoms in Alzheimer’s Disease, Mild Cognitive Impairment, and Subjective Memory Complaints: A Unified Framework7
An Inverse Association Between the Composite Dietary Antioxidant Index and Alzheimer’s Disease: Evidence from an NHANES-Based Cross-Sectional Study7
Microglial Modulation in Alzheimer’s Disease: Central Players in Neuroinflammation and Pathogenesis7
Research Progress of Mitophagy in Alzheimer's Disease7
Proposed Therapeutic Strategy to Combat Alzheimer’s Disease by Targeting Beta and Gamma Secretases7
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum7
Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer’s Disease6
Climate Change and Global Warming: Are Individuals with Dementia - Including Alzheimer’s Disease - At a Higher Risk?6
Comprehensive Insights into Pathophysiology of Alzheimer's Disease: Herbal Approaches for Mitigating Neurodegeneration6
Research Progress on the Pathogenesis, Therapeutic Strategies, andPhthalocyanine Compounds for Alzheimer's Disease6
Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease6
The Postoperative Effects of Anesthesia Exposure on Cognitive Decline in Older Adults: A Narrative Review6
Disruptions of Gut Microbiota are Associated with Cognitive Deficit of Preclinical Alzheimer's Disease: A Cross-Sectional Study6
Neuroprotective Agents: Implications for Parkinson's Disease Treatment6
Effects of DW2009 on BDNF Levels as a Secondary Analysis of a Randomized Controlled Trial Across Sociodemographic Subgroups6
Environmental Enrichment and Metformin Combination Improves Cognitive Function through BDNF and HPA Axis in Chronically Stressed Rats6
Network Pharmacology of miR-146a-5p as a Potential Anti-Inflammatory Agent in Preventing Alzheimer's Disease6
Decoding microRNA-Protein Interaction Networks in Alzheimer’s Disease: Molecular Mechanisms and Clinical Implications6
Therapeutic Effects of Arctiin on Alzheimer's Disease-like Model in Rats by Reducing Oxidative Stress, Inflammasomes and Fibrosis6
Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features6
Evidence of Clinical Efficacy and Pharmacological Mechanisms of Resveratrol in the Treatment of Alzheimer’s Disease6
Prospective Memory in Mobile: Using Smartphone-Based Calendars to Rehabilitate Prospective Memory in Patients with Alzheimer’s Disease5
Identification of MicroRNA Drug Targets for Alzheimer's and Diabetes Mellitus Using Network Medicine5
Association Between Cannabis Use and Subjective Cognitive Decline: Findings from the Behavioral Risk Factor Surveillance System (BRFSS)5
The Role of Microglial Cells and Cytokine Modulation in Alzheimer’s Disease: A Neuroinflammatory Perspective5
Post-Hoc Assessment of Cognitive Efficacy in Alzheimer’s Disease Using a Latent Growth Mixture Model in AMBAR, a Phase 2B Randomized Controlled Trial5
Effects of Metformin on Modulating the Expression of Brain-related Genes of APP/PS1 Transgenic Mice based on Single Cell Sequencing5
Uncovering the Impact of Aggrephagy in the Development of Alzheimer's Disease: Insights Into Diagnostic and Therapeutic Approaches from Machine Learning Analysis5
White Matter Damage in Alzheimer’s Disease: Contribution of Oligodendrocytes5
Exploring Potential of Nano-formulations in the Treatment of Alzheimer’s Disease through Nasal Route5
Microglial Circadian Rhythms and Neurodegenerative Diseases5
Clinical and Medication Factors Associated with Cognitive Decline in Dementia: A Healthcare Database Study5
The Immunopathy of Alzheimer’s Disease: Innate or Adaptive?5
History of Senile Dementia from the Antiquity to the Beginning of the Modern Age5
Age- and Genotype-Dependent Effects of Chronic Nicotine on Presenilin1/2 Double Knockout Mice: From Behavior to Molecular Pathways5
Complex Processes Underlying the Dynamic Changes of D-serine Levels in AD Brains5
Prenatal Exposure to the 1944-45 Dutch Famine and Risk for Dementia up to Age 75: An Analysis of Primary Care Data5
Impact of COVID-19 Mandatory Lockdown Measures on Cognitive and Neuropsychiatric Symptoms in Persons with Alzheimer's Disease in Lima, Peru4
Exploring the Mechanism of Saponins from Panax japonicus in Improving Alzheimer’s Disease Based on Network Pharmacology and Molecular Docking4
Assessment of the Inhibition of AChE and BChE by Carthamus caeruleus Essential Oil and Carline Oxide: Neuroprotective Effects and In Vivo Toxicity Assessment for the Management of Alzheimer’s D4
Effect of Transcranial Pulse Stimulation for the Treatment of Alzheimer´s Disease and its Related Symptoms4
High Frequency Repetitive Transcranial Magnetic Stimulation Improves Cognitive Performance Parameters in Patients with Alzheimer’s Disease – An Exploratory Pilot Study4
Associations between the Use of Metformin and Behavioral and Psychological Symptoms in Patients with Alzheimer´s Disease, and Type 2 Diabetes Mellitus – A Register-based Study4
Antipsychotics in Alzheimer’s Disease: Current Status and Therapeutic Alternatives4
Triglyceride Level- and MTHFR-Specific Mediation Effect of Handgrip Strength on the Association of Dietary Protein Intake and Cognitive Function in the Chinese Elderly4
Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis4
Follow-up Comparisons of Two Plasma Biomarkers of Alzheimer’s Disease, Neurofilament Light Chain, and Oligomeric Aβ: A Pilot Study4
Plasma Biomarkers in Neurodegenerative Dementias: Unrevealing the Potential of Serum Oxytocin, BDNF, NPTX1, TREM2, TNF-alpha, IL-1 and Prolactin4
A Multimodal Framework for Alzheimer’s Prevention: Diet, Exercise, Fasting, Sleep, and Gut Microbiota4
Acknowledgements to Reviewers4
Multimodal Deep Learning Approaches for Early Detection of Alzheimer’s Disease: A Comprehensive Systematic Review of Image Processing Techniques4
Serum Biomarkers of Vascular Dysfunction, Neuropsychiatric Symptoms, and Clinical Severity of Alzheimer’s Disease: A Cross-sectional Study4
Associations of Multimorbidity with Cerebrospinal Fluid Biomarkers for Neurodegenerative Disorders in Early Parkinson's Disease: A Crosssectional and Longitudinal Study4
An Online Shared Decision-making Intervention for Dementia Prevention: A Parallel-group Randomized Pilot Study4
Relation between Cerebrospinal Fluid Catecholamines and Vascular Risk Factors, Thyroid Function and Vitamins in Healthy Individuals and Patients with Neurodegenerative Diseases4
Roflumilast Protects against Neuroinflammatory Alterations in Brain Tissues of Lipopolysaccharide-induced Mice Model3
Extracellular Vesicles: A Promising Therapeutic Approach to Alzheimer's Disease3
Childhood Maltreatment and Dementia Risk Factors in Midlife: A Prospective Investigation3
Unlocking Neuroprotection: Potassium Channel Openers in Alzheimer's Disease3
Toxic Advanced Glycation End-Products-Dependent Alzheimer’s Disease- Like Alternation in the Microtubule System3
Trace Element Concentration and Cognitive Dysfunction in Elderly Residents in Birjand3
The Association between Vitamin D Deficiency and Changes in Cognitive Functions in Chinese Older Adults: A Prospective Cohort Study3
Efficacy of Sodium Valproate in Behavioral and Psychological Symptoms of Dementia: A Retrospective Observational Study from PUMCH Dementia Cohort3
How to Safely and Effectively Apply High-Intensity Strength Training in Older Adults with Alzheimer's Disease: A Case Report3
Neuroprotective Effects of Fenugreek Leaf Extract in a Drosophila Model of Alzheimer's Disease Expressing Human Aβ-423
MicroRNA Signatures in Alzheimer’s Disease and Normal-Tension Glaucoma: A Comparative Expression Analysis of miR-128 and miR-455-3p3
Tauopathy in AD: Therapeutic Potential of MARK-43
Dietary Components and Nutritional Strategies for Dementia Prevention in the Elderly3
Vagus Nerve Stimulation in the Management of Neurodegenerative Diseases: A Systematic Review of Advances in Animal Research and Clinical Applications3
ROCK Inhibitor Fasudil Attenuates Neuroinflammation and Associated Metabolic Dysregulation in the Tau Transgenic Mouse Model of Alzheimer’s Disease3
Alzheimer's Disease: Silent Erosion of Memory - From Discovery to Modern Crisis and the Quest for a Cure3
Unraveling the Intricacies: The Role of miRNAs in the Progression and Initiation of Alzheimer's Disease3
Integrative Perspectives on Neurodegeneration and Aging: From Molecular Insights to Therapeutic Strategies3
Association between Obesity and Cognitive Function in Chinese Older Adults: The Mediating Effects of Sleep Quality and Blood Pressure3
A DTI-Radiomics and Clinical Integration Model for Predicting MCI-to-AD Progression Using Corpus Callosum Features3
Sleep Characteristics in Older Adults with Different Levels of Risk for Dementia: A Cross-sectional Study3
Correlations between Cerebrospinal Fluid Biomarkers and Gray Matter Atrophy in Alzheimer's and Behavioural Variant Frontotemporal Dementia3
Alzheimer's Disease and Suicide: An Integrative Literature Review3
RNA Hypomethylation and Unchanged DNA Methylation Levels in the Cortex of ApoE4 Carriers and Alzheimer’s Disease Subjects3
Blood Biomarkers Discriminate Cerebral Amyloid Status and Cognitive Diagnosis when Collected with ACD-A Anticoagulant3
Effect of Ascorbic Acid on the Transgenic Drosophila Expressing Human Aβ-42 in the Neurons3
Preclinical Pharmacology of CX1837, a High-Impact Ampakine with an Improved Safety Margin: Implications for Treating Alzheimer’s Disease and Ischemic Stroke3
hdWGCNA and Cellular Communication Identify Active NK Cell Subtypes in Alzheimer's Disease and Screen for Diagnostic Markers through Machine Learning3
A Review on the Use of Modern Computational Methods in Alzheimer’s Disease-Detection and Prediction3
Interactions of Polyphenolic Gallotannins with Amyloidogenic Polypeptides Associated with Alzheimer’s Disease: From Molecular Insights to Physiological Significance3
Molecular Signatures and Clinical Significance of Notch Signaling Pathway in Peripheral Blood of Patients with Alzheimer's Disease2
The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship2
A Look at the Etiology of Alzheimer's Disease based on the Brain Ischemia Model2
Innovative Approaches in Molecular Docking for the Discovery of Novel Inhibitors Against Alzheimer's Disease2
Advances in Alzheimer's Disease Biomarkers2
Connectivity between Gut Microbiota and Terminal Awakenings in Alzheimer’s Disease2
Corrigendum to: Lithium Chloride Improves Electrophysiological and Memory Deficits in Rats with Streptozotocin-Induced Alzheimer's Disease2
Different Patterns of Locus Coeruleus MRI Alteration in Alzheimer’s and Dementia with Lewy Bodies2
Association of Brain and Ventricular Boundary Shift Integral Measurements with CSF Biomarkers: A Case-Control Study2
miRNAs: Promising Biomarkers for Alzheimer's Diagnosis and Treatment2
Neuroimaging Genetics and Network Analysis in Alzheimer’s Disease2
Clinical Study on the Neuroprotective Effects of Dengzhan Shengmai Capsule on Brain Structure and Cognitive Function in Patients with Vascular Cognitive Impairment2
Handwriting Markers for the Onset of Alzheimer’s Disease2
Association of Autoimmune Disorders and Disease-modifying Antirheumatic Drugs: (DMARDs) with the Risk of Alzheimer’s and/or Dementia: A Population Study Using Medicare Beneficiary Data2
Gut Microbiota Dysbiosis in Alzheimer’s Disease and Possible Therapeutic Options2
BACE-1 Inhibitors Targeting Alzheimer's Disease2
Cognitive Advantage of Bilingualism Over Monolingualism in Older Adults: A Meta-Analysis2
Therapeutic Advances in Alzheimer’s Disease: Integrating Natural, Semi-Synthetic, and Synthetic Drug Strategies2
Serum Sirtuin-1, HMGB1-TLR4, NF-KB and IL-6 Levels in Alzheimer’s: The Relation Between Neuroinflammatory Pathway and Severity of Dementia2
A New Hope in Alzheimer's Disease Psychosis: Pimavanserin2
Alterations of Cerebral Blood Flow and its Connectivity Patterns Measured with Arterial Spin Labeling in Mild Cognitive Impairment2
An In silico Multi-Omics Investigation of Alzheimer's Disease Linking Gene Dysregulation, Mutations, and Protein Networks to Core Pathologies2
The Potential Role of Enrichment Environment on Plasticity in Alzheimer's Disease Models: Insights About Therapeutic Approaches2
Relationship between Alzheimer's Disease and Type 2 Diabetes: Critical Review On Cellular and Molecular Common Pathogenic Mechanisms2
RESIGN: Alzheimer's Disease Detection Using Hybrid Deep Learning based Res-Inception Seg Network2
Auditory Hallucinations as the First Symptom of Alzheimer´s Disease – A Case Report2
Capgras Syndrome in Dementia: A Systematic Review of Case Studies2
Towards the Integrative Theory of Alzheimer’s Disease: Linking Molecular Mechanisms of Neurotoxicity, Beta-amyloid Biomarkers, and the Diagnosis2
Dysregulation of Porphyromonas gingivalis Agmatine Deiminase Expression in Alzheimer’s Disease2
Sodium-to-Potassium Ratio and Alzheimer’s Disease: A Mendelian Randomization Study2
Association Between Serum Lipid Traits and Cognitive Function in Middle-aged and Elderly Adults: A Longitudinal Study2
Correlations between SHBG, Sex Hormones, Inflammation, and Neurocognitive Decline in Alzheimer's Disease: A Retrospective Study2
T Lymphocytes in the Pathogenesis and Progression of Alzheimer’s Disease: Pursuing Direct Neuropathological Evidence2
0.040224075317383